Youxin Ji

2.0k total citations
58 papers, 1.4k citations indexed

About

Youxin Ji is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Youxin Ji has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Youxin Ji's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Colorectal Cancer Treatments and Studies (10 papers). Youxin Ji is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Colorectal Cancer Treatments and Studies (10 papers). Youxin Ji collaborates with scholars based in China, United States and Netherlands. Youxin Ji's co-authors include Ping Wang, Mian Zhou, Rongqian Wu, Weifeng Dong, Xiaoling Qiang, Thanjavur S. Ravikumar, Asha Jacob, Weng-Lang Yang, Haichao Wang and Gene F. Coppa and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Youxin Ji

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youxin Ji China 18 448 407 256 245 236 58 1.4k
Peiying Shan United States 20 1.2k 2.6× 547 1.3× 185 0.7× 451 1.8× 208 0.9× 26 2.0k
Guochang Hu United States 25 847 1.9× 471 1.2× 149 0.6× 453 1.8× 320 1.4× 46 2.0k
Joel Linden United States 21 648 1.4× 385 0.9× 92 0.4× 112 0.5× 188 0.8× 29 1.8k
Vijay Patel United States 27 627 1.4× 203 0.5× 179 0.7× 188 0.8× 312 1.3× 107 1.7k
Yimu Yang United States 18 430 1.0× 252 0.6× 527 2.1× 341 1.4× 165 0.7× 47 1.8k
Joëlle Perez France 26 739 1.6× 432 1.1× 205 0.8× 259 1.1× 225 1.0× 51 2.0k
Thomas J. Ferro United States 21 608 1.4× 392 1.0× 178 0.7× 409 1.7× 502 2.1× 54 1.7k
Michael R. Wilson United Kingdom 23 520 1.2× 411 1.0× 134 0.5× 864 3.5× 65 0.3× 44 1.5k
Kaushik Parthasarathi United States 19 491 1.1× 165 0.4× 78 0.3× 456 1.9× 260 1.1× 42 1.2k
Jeffrey Mewburn Canada 24 850 1.9× 201 0.5× 177 0.7× 643 2.6× 314 1.3× 53 2.0k

Countries citing papers authored by Youxin Ji

Since Specialization
Citations

This map shows the geographic impact of Youxin Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youxin Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youxin Ji more than expected).

Fields of papers citing papers by Youxin Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youxin Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youxin Ji. The network helps show where Youxin Ji may publish in the future.

Co-authorship network of co-authors of Youxin Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Youxin Ji. A scholar is included among the top collaborators of Youxin Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youxin Ji. Youxin Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Youxin, et al.. (2024). Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations. International Journal of General Medicine. Volume 17. 5503–5510. 1 indexed citations
2.
Zheng, Lu, Junying Zhou, Youxin Ji, et al.. (2024). 54P BL-B01D1, an EGFR x HER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic biliary tract carcinoma (BTC). Annals of Oncology. 35. S233–S233. 2 indexed citations
6.
Zhang, Ling, et al.. (2019). Bevacizumab Combined with Icotinib Overcomes Osimertinib Resistance in a Patient of Non-Small Cell Lung Cancer. Chinese Medical Sciences Journal. 34(4). 292–296.
7.
Zhang, Chunling, et al.. (2019). Preliminary study of S-1 maintenance therapy in extensive stage small-cell lung cancer.. Journal of Clinical Oncology. 37(15_suppl). e20080–e20080. 1 indexed citations
8.
Zhang, Ling, et al.. (2018). Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report. Cancer Biology and Medicine. 15(2). 178–178. 12 indexed citations
9.
Liu, Shichao, et al.. (2018). Treatment of Skin Reaction Induced by Nivolumab Combined with Radiotherapy in Non-small Cell Lung Cancer: A Case Report. Chinese Medical Sciences Journal. 33(3). 183–187. 7 indexed citations
10.
11.
Zhang, Ling, Shichao Liu, Zhongfa Zhang, et al.. (2016). Clinical Observation of Bevacizumab Combined with S-1 in the Treatment of Pretreated Advanced Esophageal Carcinoma. Chinese Medical Sciences Journal. 31(4). 221–227. 4 indexed citations
12.
Xu, Jing, et al.. (2016). Primary seminoma arising in the middle mediastinum: A case report. Oncology Letters. 12(1). 348–350. 9 indexed citations
13.
Liu, Haiying, et al.. (2011). A modified surgical technique in the management of eyelid burns: a case series. Journal of Medical Case Reports. 5(1). 373–373. 13 indexed citations
14.
Miksa, Michael, Rongqian Wu, Weifeng Dong, et al.. (2009). Immature Dendritic Cell-Derived Exosomes Rescue Septic Animals Via Milk Fat Globule Epidermal Growth Factor VIII. The Journal of Immunology. 183(9). 5983–5990. 96 indexed citations
15.
Wu, Rongqian, Mian Zhou, Weifeng Dong, et al.. (2009). Ghrelin Hyporesponsiveness Contributes to Age-Related Hyperinflammation in Septic Shock. Annals of Surgery. 250(1). 126–133. 30 indexed citations
16.
Wu, Rongqian, Weifeng Dong, Youxin Ji, et al.. (2009). Reversing Established Sepsis in Rats with Human Vasoactive Hormone Adrenomedullin and its Binding Protein. Molecular Medicine. 15(1-2). 28–33. 17 indexed citations
17.
Miksa, Michael, Padmalaya Das, Mian Zhou, et al.. (2009). Pivotal Role of the α2A-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of Sepsis. PLoS ONE. 4(5). e5504–e5504. 80 indexed citations
18.
Wu, Rongqian, Weifeng Dong, Xiaoling Qiang, et al.. (2008). Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock. Peptides. 29(7). 1223–1230. 11 indexed citations
19.
Qiang, Xiaoling, Rongqian Wu, Youxin Ji, Mian Zhou, & Ping Wang. (2008). Purification and Characterization of Human Adrenomedullin Binding Protein-1. Molecular Medicine. 14(7-8). 443–450. 10 indexed citations
20.
Wu, Rongqian, Mian Zhou, Padmalaya Das, et al.. (2007). Ghrelin inhibits sympathetic nervous activity in sepsis. American Journal of Physiology-Endocrinology and Metabolism. 293(6). E1697–E1702. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026